Tag: CEO
Eye drops to cut need for reading glasses?
PresVu, said to be India's first eye drop for people suffering from presbyopia, is set to hit the market in October this year. The...
Philips delivers strong order intake growth in the second quarter
In the second quarter, Philips completed the EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021,...
India faces steep blood cancer mortality rates with over 70,000 annual...
With over 70,000 annual deaths stemming from blood cancer, India experiences a huge burden of mortality rates from this disease. As per the Globocan...
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign
The escalating incidences of head and neck cancers are profoundly influenced by the interplay of tobacco and alcohol consumption. These two primary risk factors...
PharmNovo awarded blended funding of €17.5M from EIC
PharmNovo, a Swedish clinical-stage pharmaceutical company, has been awarded €17.5 M in blended funding from the European Innovation Council (EIC) Accelerator under the Horizon...
DocMode launches clinical research services
DocMode Health Technologies, a leading Med-Tech Ecosystem, has announced the launch of its new Clinical Research Services. This expansion marks a significant milestone in...
Nordic Bioproducts group receives pharmaceutical industry’s EXCiPACT certification
Nordic Bioproducts Group today announces that its new manufacturing factory in Lappeenranta, Finland, has received the prestigious EXCiPACT certification for the production of microcrystalline cellulose (MCC). This certification...
Archies and Revaa join forces to celebrate Menstrual Hygiene Day
Archies, renowned as India’s foremost name in social expression, and Revaa, a leading D2C menstrual hygiene brand, announced their partnership on the occasion of...
Gerresheimer to acquire Blitz LuxCo Sarl
Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, has signed a purchase agreement with funds advised by Triton ("Triton") for the acquisition of...
PharmNovo scores in neuropathic pain management
Swedish pharmaceutical company PharmNovo has announced the positive final results from the Phase I trial of its neuropathic pain drug candidate, PN6047. This trial...